These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10599407)

  • 41. [Helicobacter pylori infection diagnosis in dyspeptic patients from the City of San Luis, Argentina, using invasive methods].
    Vega AE; Mattana CM; Gómez P; Majul R; de Centorbi ON
    Rev Argent Microbiol; 2000; 32(2):104-8. PubMed ID: 10885011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
    Rich K; Safranek S; Malaty W
    J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
    [No Abstract]   [Full Text] [Related]  

  • 43. [Approaches to diagnosis and treatment of dyspepsia].
    Jarbøl DE; Kjeldsen HC; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3385-8. PubMed ID: 15515390
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should all dialysis patients be screened and treated for Helicobacter pylori preemptively before renal transplant?
    Mukhtar A; Malik TQ; Karkar A
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):232-3. PubMed ID: 16903635
    [No Abstract]   [Full Text] [Related]  

  • 46. [Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].
    Kashnikova SN; Shcherbakov PL; Kashnikov VV; Tatarinov PA; Shcherbakova MIu
    Eksp Klin Gastroenterol; 2008; (7):111-8. PubMed ID: 19334454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic evaluations to aid decision to conduct a trial.
    Jefferson T
    Lancet; 1996 Jul; 348(9021):141. PubMed ID: 8684148
    [No Abstract]   [Full Text] [Related]  

  • 48. Editorial: population-based testing for Helicobacter pylori in Western countries.
    Vakil N
    Aliment Pharmacol Ther; 2019 May; 49(10):1360. PubMed ID: 31016767
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cost of esophago-gastro-duodenal endoscopy].
    Martin D; Pallud D; Fauconnier J; Capony P
    Gastroenterol Clin Biol; 1993; 17(6-7):508-9. PubMed ID: 8243943
    [No Abstract]   [Full Text] [Related]  

  • 50. Per-procedure endoscopy costs.
    Schroy PC
    Gastrointest Endosc; 1997 Jul; 46(1):90-1. PubMed ID: 9260718
    [No Abstract]   [Full Text] [Related]  

  • 51. Empirical treatment or prompt endoscopy.
    Laheij RJ; Severens JL; Jansen JB
    Lancet; 2001 Apr; 357(9265):1366. PubMed ID: 11347585
    [No Abstract]   [Full Text] [Related]  

  • 52. Willful ignorance in decision making against or in favor of endoscopy.
    Sonnenberg A; Bauerfeind P
    United European Gastroenterol J; 2020 Feb; 8(1):5-8. PubMed ID: 32213051
    [No Abstract]   [Full Text] [Related]  

  • 53. Indigenous endoscopic accessories.
    Nijhawan S
    Indian J Gastroenterol; 2003; 22(3):94-7. PubMed ID: 12839381
    [No Abstract]   [Full Text] [Related]  

  • 54. Cost effectiveness should count in choosing a strategy for eradicating helicobacter pylori.
    BMJ; 1998 May; 316(7145):D. PubMed ID: 9603778
    [No Abstract]   [Full Text] [Related]  

  • 55. Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia.
    Ladabaum U; Fendrick AM; Scheiman JM
    Am J Gastroenterol; 2001 Jul; 96(7):2051-7. PubMed ID: 11467631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-benefit analysis of Helicobacter pylori screening.
    Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
    Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
    You JH; Wong PL; Wu JC
    Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The health economics of Helicobacter pylori infection.
    Moayyedi P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [How much does it cost eradicating Helicobacter pylori in Argentine?].
    Man F
    Acta Gastroenterol Latinoam; 1999; 29(4):285-7. PubMed ID: 10599407
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.